中华医学杂志
中華醫學雜誌
중화의학잡지
National Medical Journal of China
2012年
26期
1854-1857
,共4页
高胆固醇血症%线粒体%心肌%阿托伐他汀%辅酶Q10
高膽固醇血癥%線粒體%心肌%阿託伐他汀%輔酶Q10
고담고순혈증%선립체%심기%아탁벌타정%보매Q10
Hypercholesterolemia%Mitochondria heart%Atorvastatin%Coenzyme Q10
目的 探讨阿托伐他汀和辅酶Q10对高胆固醇血症兔心肌损伤和心肌能量代谢的干预作用.方法40只健康雄性新西兰兔分成5组:正常对照组、高胆固醇组、他汀组、辅酶Q10(5 mg/kg)1组、辅酶Q10(10mg/kg)2组.喂养6周后,取静脉空腹血标本测血清总胆固醇(TC)的浓度;取心肌组织,电镜观察线粒体超微结构改变;用高效液相色谱法测心肌线粒体ATP和辅酶Q10含量;用紫外分光光度法测线粒体呼吸链复合物Ⅱ、Ⅳ的活性.结果高胆固醇组心肌纤维排列紊乱,部分断裂、溶解,线粒体肿胀,嵴紊乱、模糊,与对照组比较,高胆固醇组线粒体呼吸链复合物Ⅱ、Ⅳ活性下降[分别为(μmol·min-1·mg-1)5.39±0.53比12.95±0.99,1.89±0.26比6.65±0.95,P<0.01],线粒体ATP、辅酶Q10含量减少[分别为(mg/L)0.17±0.05比0.44士0.06,0.09±0.02比0.25 ±0.04,P<0.01];他汀组与高胆固醇组比较,呼吸链复合物Ⅱ、Ⅳ活性升高[分别为(μmol·min-1·mg-1)9.12±1.19比5.39±0.53,4.61±0.52比1.89±0.26,P<0.01].线粒体ATP、辅酶Qi0含量差异无统计学意义.辅酶Q101组与他汀组比较,呼吸链复合物Ⅱ、Ⅳ活性差异无统计学意义;线粒体ATP、辅酶Q10含量增加[分别为(mg/L)0.35±0.03比0.16 ±0.04,0.17±0.02比0.07.±0.02,P<0.01].辅酶Q102组与辅酶Q101组比较,各指标差异无统计学意义.结论高胆固醇血症可导致心肌超微结构改变及线粒体能量代谢障碍,阿托伐他汀可减轻心肌结构损伤,阿托伐他汀联合辅酶Q10可进一步改善心肌线粒体能量代谢障碍.
目的 探討阿託伐他汀和輔酶Q10對高膽固醇血癥兔心肌損傷和心肌能量代謝的榦預作用.方法40隻健康雄性新西蘭兔分成5組:正常對照組、高膽固醇組、他汀組、輔酶Q10(5 mg/kg)1組、輔酶Q10(10mg/kg)2組.餵養6週後,取靜脈空腹血標本測血清總膽固醇(TC)的濃度;取心肌組織,電鏡觀察線粒體超微結構改變;用高效液相色譜法測心肌線粒體ATP和輔酶Q10含量;用紫外分光光度法測線粒體呼吸鏈複閤物Ⅱ、Ⅳ的活性.結果高膽固醇組心肌纖維排列紊亂,部分斷裂、溶解,線粒體腫脹,嵴紊亂、模糊,與對照組比較,高膽固醇組線粒體呼吸鏈複閤物Ⅱ、Ⅳ活性下降[分彆為(μmol·min-1·mg-1)5.39±0.53比12.95±0.99,1.89±0.26比6.65±0.95,P<0.01],線粒體ATP、輔酶Q10含量減少[分彆為(mg/L)0.17±0.05比0.44士0.06,0.09±0.02比0.25 ±0.04,P<0.01];他汀組與高膽固醇組比較,呼吸鏈複閤物Ⅱ、Ⅳ活性升高[分彆為(μmol·min-1·mg-1)9.12±1.19比5.39±0.53,4.61±0.52比1.89±0.26,P<0.01].線粒體ATP、輔酶Qi0含量差異無統計學意義.輔酶Q101組與他汀組比較,呼吸鏈複閤物Ⅱ、Ⅳ活性差異無統計學意義;線粒體ATP、輔酶Q10含量增加[分彆為(mg/L)0.35±0.03比0.16 ±0.04,0.17±0.02比0.07.±0.02,P<0.01].輔酶Q102組與輔酶Q101組比較,各指標差異無統計學意義.結論高膽固醇血癥可導緻心肌超微結構改變及線粒體能量代謝障礙,阿託伐他汀可減輕心肌結構損傷,阿託伐他汀聯閤輔酶Q10可進一步改善心肌線粒體能量代謝障礙.
목적 탐토아탁벌타정화보매Q10대고담고순혈증토심기손상화심기능량대사적간예작용.방법40지건강웅성신서란토분성5조:정상대조조、고담고순조、타정조、보매Q10(5 mg/kg)1조、보매Q10(10mg/kg)2조.위양6주후,취정맥공복혈표본측혈청총담고순(TC)적농도;취심기조직,전경관찰선립체초미결구개변;용고효액상색보법측심기선립체ATP화보매Q10함량;용자외분광광도법측선립체호흡련복합물Ⅱ、Ⅳ적활성.결과고담고순조심기섬유배렬문란,부분단렬、용해,선립체종창,척문란、모호,여대조조비교,고담고순조선립체호흡련복합물Ⅱ、Ⅳ활성하강[분별위(μmol·min-1·mg-1)5.39±0.53비12.95±0.99,1.89±0.26비6.65±0.95,P<0.01],선립체ATP、보매Q10함량감소[분별위(mg/L)0.17±0.05비0.44사0.06,0.09±0.02비0.25 ±0.04,P<0.01];타정조여고담고순조비교,호흡련복합물Ⅱ、Ⅳ활성승고[분별위(μmol·min-1·mg-1)9.12±1.19비5.39±0.53,4.61±0.52비1.89±0.26,P<0.01].선립체ATP、보매Qi0함량차이무통계학의의.보매Q101조여타정조비교,호흡련복합물Ⅱ、Ⅳ활성차이무통계학의의;선립체ATP、보매Q10함량증가[분별위(mg/L)0.35±0.03비0.16 ±0.04,0.17±0.02비0.07.±0.02,P<0.01].보매Q102조여보매Q101조비교,각지표차이무통계학의의.결론고담고순혈증가도치심기초미결구개변급선립체능량대사장애,아탁벌타정가감경심기결구손상,아탁벌타정연합보매Q10가진일보개선심기선립체능량대사장애.
Objective To explore the interventional effects of atorvastatin and CoQ10 on myocardial energy metabolism in rabbits with hypercholesterolemia.Methods Forty male New Zealand white rabbits were randomly divided into 5 groups:i.e.normal control,high cholesterol,statin,coenzyme Q10 1 and coenzyme Q10 2.After feeding for 6 weeks,the fasting blood samples were collected through ear marginal vein and the serum level of total cholesterol was determined.Myocardium was sampled for ultrastructures by electron microscopy; high-performance liquid chromatography (HPLC) was used to measure myocardial mitochondria adenosine triphosphate (ATP) and coenzyme CoQ10.Ultraviolet spectrophotometry was used to measure the activities of mitochondrial complexes Ⅱ and Ⅳ.Results In high cholesterol group,myocardial fibers were arrayed disorderly with partial rupture and dissolution.There was mitochondrial swelling with disorderly and fuzzy cristae.As compared with the controls,the activities of mitochondrial respiratory chain complexes Ⅱand Ⅳ declined (5.39 ±0.53 vs 12.95±0.99,1.89 ±0.26 vs6.65 ±0.95,P<0.01),the contents of mitochondrial ATP and CoQ10 decreased (0.17 ± 0.05 vs 0.44 ± 0.06,0.09 ± 0.02 vs 0.25 ±0.04,P <0.01 ) ; for statin group versus high cholesterol group,the activities of mitochondrial respiratory chain complexes Ⅱ and Ⅳ increased (9.12 ± 1.19 vs 5.39 ± 0.53,4.61 ± 0.52 vs 1.89 ± 0.26,P <0.01 ) ; the content differences of mitochondrial ATP and CoQ10 were statistically insignificant.For CoQ10 1group versus statin group,the differences of respiratory chain complexes Ⅱ and Ⅳ were statistically insignificant; the contents of mitochondria ATP and CoQ10 increased (0.35 ±0.03 vs 0.16 ±0.04,0.17±0.02 vs 0.07 ± 0.02,P < 0.01 ).For coenzyme Q10 2 group versus coenzyme Q10 1 group,none of the indices was statistically significant.Conclusion High cholesterol can cause myocardial ultrastructural changes and impaired mitochondrial energy metabolism.Atorvastatin reduces the myocardial structural damage and the combination of atorvastatin and CoQ10 may further improve the myocardial mitochondrial energy metabolism.